Sign Up
SB 2098 Hawaii Senate · 2020 Regular Session

RELATING TO FOOD SAFETY.

Summary
Appropriates funds to the Department of Business, Economic Development, and Tourism to provide education and support to local businesses regarding compliance with the federal Food and Drug Administration's industry guidance on colored sea salt. Requires private industry businesses to collectively pay 50% of the cost to conduct and submit to the federal Food and Drug Administration any research, studies, or analysis required for federal Food and Drug Administration approval of color additives used in Hawaii sea salt. Effective 7/1/2050. (SD1)
Bill status passed 3 of 5 stages cleared
Introduction
Jan 2020
Committee Review
Jun 2020
Senate Passage
Mar 2020
House Passage
Governor
Introduced Jan 17, 2020 Last action Jun 22, 2020
Floor votes

How they voted

This bill passed the Senate. No roll call record of that vote is available.
Full legislative history

Actions timeline

Total actions
22
Key actions
8
Committee
11
Jun 22, 2020
Lower · Passed
The committee(s) on EDB recommend(s) that the measure be deferred.
lower
Mar 13, 2020
Lower · Passed
The committee(s) on EDB recommend(s) that the measure be deferred until 03-18-20.
lower
Mar 9, 2020
Committee
Referred to EDB, FIN, referral sheet 36
lower
Mar 3, 2020
Introduced
Received from Senate (Sen. Com. No. 116) in amended form (SD 1).
lower
Mar 3, 2020
Upper · Passed
Report adopted; Passed Third Reading, as amended (SD 1). Ayes, 25; Aye(s) with reservations: none . Noes, 0 (none). Excused, 0 (none). Transmitted to House.
upper
Feb 20, 2020
Upper · Passed
The committee(s) on WAM recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in WAM were as follows: 9 Aye(s): Senator(s) Dela Cruz, Keith-Agaran, Harimoto, Kanuha, Kidani, Moriwaki, Riviere, Shimabukuro, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 4 Excused: Senator(s) English, Inouye, K. Kahele, Taniguchi.
upper
Feb 18, 2020
Upper · Passed
The committee(s) on WAM will hold a public decision making on 02-20-20 1:00PM in conference room 211.
upper
Feb 13, 2020
Committee
Report adopted; Passed Second Reading and referred to WAM.
upper
Feb 13, 2020
Committee
Reported from EET/CPH (Stand. Com. Rep. No. 2688) with recommendation of passage on Second Reading and referral to WAM.
upper
Feb 10, 2020
Upper · Passed
The committee(s) on EET recommend(s) that the measure be PASSED, UNAMENDED. The votes in EET were as follows: 4 Aye(s): Senator(s) Wakai, Inouye, J.Keohokalole; Aye(s) with reservations: Senator(s) Taniguchi ; 0 No(es): none; and 1 Excused: Senator(s) Fevella.
upper
Feb 10, 2020
Upper · Passed
The committee(s) on CPH recommend(s) that the measure be PASSED, UNAMENDED. The votes in CPH were as follows: 4 Aye(s): Senator(s) S. Chang, Nishihara, Wakai; Aye(s) with reservations: Senator(s) Baker ; 0 No(es): none; and 3 Excused: Senator(s) Ruderman, L. Thielen, Fevella.
upper
Feb 6, 2020
Upper · Passed
The committee(s) on EET/CPH has scheduled a public hearing on 02-10-20 2:45PM in conference room 414.
upper
Jan 17, 2020
Committee
Referred to EET/CPH, WAM.
upper
Jan 17, 2020
Introduced
Introduced.
upper
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.